The Fund seeks to actively seek capital growth through investment primarily in UK equities.
Name | % Net Assets |
---|---|
BP | 7.3% |
HSBC | 7.0% |
Royal Dutch Shell B | 6.7% |
Vodafone Group | 6.6% |
Glaxosmithkline | 4.4% |
BG Group | 4.3% |
Astrazeneca | 4.1% |
British American Tobacco | 4.0% |
Xstrata | 4.0% |
Imperial Tobacco Group | 3.5% |
Key | % Net Assets |
---|---|
![]() |
7.3% |
![]() |
7.0% |
![]() |
6.7% |
![]() |
6.6% |
![]() |
72.4% |
Date | 25-Apr-2025 |
---|---|
NAV | 209.90p |
Currency | GBP |
Change | 1.70p |
% | 0.35% |
YTD change | -3.00p |
YTD % | -0.61% |
Fund Inception | 18/06/1981 |
---|---|
Fund Manager | Bradley Mitchell |
TER | 1.40 |
Minimum Investment | |
---|---|
Initial | £5000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.08 |
You are here: research